Description

BSE clarifications from Thyrocare Technologies Ltd and Hemisphere Properties India Limited regarding significant movement in share volumes.

Summary

BSE sought clarifications from Thyrocare Technologies Limited (Scrip Code: 539871) and Hemisphere Properties India Limited (Scrip Code: 543242, Symbol: HEMIPROP) regarding significant increases in trading volumes. Both companies confirmed they have no pending material information to disclose and that the volume increases are purely market-driven, with management not connected to the price/volume movements.

Key Points

  • Thyrocare Technologies Ltd responded to BSE’s November 14, 2025 clarification request (Ref: L/SURV/ONL/PV/AA/2025-2026/678)
  • Hemisphere Properties India Limited responded to BSE and NSE clarification requests dated November 13-14, 2025
  • Both companies confirmed all material information has been disclosed in accordance with Regulation 30 of SEBI LODR 2015
  • Companies stated they are unaware of specific reasons for volume increases
  • Volume/price movements attributed to market forces, not management actions
  • No undisclosed price sensitive information exists

Regulatory Changes

No regulatory changes announced.

Compliance Requirements

  • Companies reaffirmed commitment to timely disclosures under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Disclosures made in accordance with respective Materiality Policies
  • Both companies confirmed adherence to Board-approved disclosure guidelines

Important Dates

  • November 13, 2025: BSE/NSE sent clarification request to Hemisphere Properties
  • November 14, 2025: BSE sent clarification request to Thyrocare Technologies
  • November 14, 2025: Both companies submitted clarification responses

Impact Assessment

Market Impact: Low - These are standard surveillance clarifications with no new material information disclosed. The responses indicate normal market activity without corporate actions or undisclosed developments.

Investor Impact: Minimal - Provides transparency that volume spikes are market-driven rather than due to pending corporate announcements. No action required from investors.

Operational Impact: None - No changes to company operations or compliance requirements.

Company Details

Thyrocare Technologies Limited

  • CIN: L85110MH2000PLC123882
  • BSE Scrip Code: 539871
  • Registered Office: D-37/1, TTC MIDC, Turbhe, Navi Mumbai-400703
  • Response signed by: Brijesh Kumar, Company Secretary and Compliance Officer

Hemisphere Properties India Limited

  • CIN: L70101DL2005GOI132162
  • BSE Scrip Code: 543242
  • NSE Symbol: HEMIPROP
  • Registered Office: Room No. I7, C-Wing, Nirman Bhawan, Maulana Azad Road, New Delhi 110001
  • Government of India Enterprise

Impact Justification

Routine surveillance clarifications with no new material information disclosed by companies; both confirmed movement is market-driven with no undisclosed price sensitive information